论文信息 - St.-Gallen-Konferenz 2011 zum primären Mammakarzinom - 字舞流文

St.-Gallen-Konferenz 2011 zum primären Mammakarzinom

Abstract

F. Jänicke | N. Harbeck | R. Kreienberg | K. Diedrich | D. Wallwiener | W. Jonat | M. Beckmann | M. Kaufmann | C. Jackisch | A. Schneeweiss | M. Untch | B. Gerber | W. Eiermann | A. Scharl | K. Friese | W. Janni | N. Maass | M. Kiechle | G. Minckwitz | S. Costa | I. Diel | C. Thomssen | V. Möbus | U. Nitz | J. Blohmer | N. Marschner | J. Hilfrich | U. Köhler

[1] Andreas Schneeweiss,et al. Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2] N. Harbeck,et al. Superiority of sequential docetaxel over standard FE100C in patients with intermediate risk breast cancer: survival results of the randomized intergroup phase III trial EC-Doc. , 2009 .

[3] M. Cronin,et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4] E. Winer,et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[6] B. Haffty,et al. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer , 2010 .